We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Test Used to Battle West Nile Virus

By LabMedica International staff writers
Posted on 26 Sep 2012
The West Nile Virus (WNV) laboratory test is performed when a person who may have had recent exposure to the virus shows possible signs and symptoms of an infection.

The test is able to confirm whether the infection exists, allowing physicians to take action to control its impact and in severe cases, this might include hospital care where patients can receive supportive treatment including intravenous fluids, help with breathing, and nursing care. More...


Laboratory diagnosis of WNV infections is generally accomplished by testing of serum or cerebrospinal fluid (CSF) to detect virus-specific IgM and neutralizing antibodies. There are four WNV IgM ELISA kits from different manufacturers that are commercially available in the USA and are approved by US Food and Drug Administration (FDA; Silver Springs, MD, USA). In serious or fatal cases, the nucleic acid amplification test (NAAT), histopathology with immunohistochemistry and virus culture of autopsy tissues can also be useful. Only a few state laboratories or other specialized laboratories are capable of doing this specialized testing.

The NAAT technique is used because it measures the WNV’s genetic material, the test can detect an infection before the antibody test. This test is routinely used to screen donated units of blood, as well as donated tissue and organs. It also can be used to test birds and mosquito pools for WNV, often before any people have been identified with the disease, which helps public health experts track the virus’s spread through the community or region. Severe symptoms of WNV can include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis.

A record-breaking 1,590 human cases of WNV have been reported in the USA during 2012, including 65 deaths, according to the US Centers for Disease Control and Prevention (CDC; Atlanta GA, USA). Alan Mertz, MA, the president of the American Clinical Laboratory Association (Washington, DC, USA), said, "The test was developed quickly to respond to WNV when it first appeared in the USA. The test is a good example of the kind of innovative tests that clinical laboratories have discovered quickly in response to new and emerging medical crises, such as human immunodeficiency virus (HIV), herpes meningitis, severe acute respiratory syndrome (SARS), Influenza A subtype H1N1, and Avian flu.”

Related Links:

US Food and Drug Administration

US Centers for Disease Control and Prevention

American Clinical Laboratory Association




Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.